Medical specialists from France tagged as investigators in clinical trials studying Leukemia, Myelomonocytic, Chronic
Total 24 results
-
Alice GARNIER, MDSeen in:
- Nantes, CHU Hotel Dieu
Trials:- NCT05226455 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
Conditions: -
Aspasia STAMATOULLAS, MDSeen in:
- Rouen, Centre Henri Becquerel
Trials:- NCT05226455 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
Conditions: -
Caroline CHARLIER-WOERTHER, MD, PhDSeen in:
- Villejuif, Gustave Roussy Institut
Trials:- NCT04953312 (Sub-Investigator)
-
Cherifa CHEURFA, MDSeen in:
- Villejuif, Gustave Roussy Institut
Trials:- NCT04953312 (Sub-Investigator)
-
Christophe WILLEKENS, MDSeen in:
- Villejuif, Institut Gustave Roussy
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Delphine LEBON, MDSeen in:
- Amiens, CHU d'AMIENS
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Didier BOUSCARY, PhDSeen in:
- Villejuif, Gustave Roussy Institut
Trials:- NCT04953312 (Sub-Investigator)
-
Emmanuel GYAN, MD/PhDSeen in:
- Tours, CHU de Tours - Hôpital Bretonneau
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Franciane PAUL, MDSeen in:
- Montpellier, CHU DE MONTPELLIER - Hopital Saint Eloi
- Montpellier, CHU Saint Eloi
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Frédéric PENE, MD, PhDSeen in:
- Villejuif, Gustave Roussy Institut
Trials:- NCT04953312 (Sub-Investigator)
-
Jacques DELAUNAY, MDSeen in:
- Nantes, Hôpital privé du Confluent SAS
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Jose Miguel TORREGROSA DIAZ, MDSeen in:
- Poitiers, CHU de Poitiers
- Poitiers, CHU de Poitiers/Pôle de cancérologie - secteur tertiaire-
Trials:- NCT03503409 (Principal Investigator)
- NCT03223961 (Principal Investigator)
- NCT04827719 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Maël HEIBLIG, MDSeen in:
- Pierre-Bénite, Centre Hospitalier Lyon Sud
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Marie-Pierre GOURIN, MDSeen in:
- Limoges, CHRU de Limoges
- Limoges, CHU de Limoges - Hôpital Dupuytren
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Norbert VEY, MD/PhDSeen in:
- Marseille, Institut Paoli Calmettes
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Raphaël ITZYKSON, MD/PhDSeen in:
- Paris, Hopital Saint Louis
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Rudy BIRSEN, MDSeen in:
- Paris, Hôpital Cochin
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Sophie PARK, MD/PhDSeen in:
- Grenoble, CHU de Grenoble
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Stanislas NIMUBONA, MDSeen in:
- Rennes, CHU Pontchaillou
- Rennes, Hopital Pontchaillou
Trials:- NCT03223961 (Principal Investigator)
- NCT04827719 (Principal Investigator)
- NCT05768711 (Principal Investigator)
-
Sylvain Thepot, MDSeen in:
- Angers, CHU Angers
- Angers, CHU d'Angers
Trials:- NCT04905407 (Principal Investigator)
- NCT05226455 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Tali-Anne SZWEBEL, MDSeen in:
- Villejuif, Gustave Roussy Institut
Trials:- NCT04953312 (Sub-Investigator)
-
Thibault COMONT, MDSeen in:
- Toulouse, IUCT Oncopole
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Thomas CLUZEAU, MD/PhDSeen in:
- Nice, Hôpital Archet 1
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Thorsten BRAUN, MD/PhDSeen in:
- Bobigny, Hôpital Avicenne
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
Clinical Trials on Leukemia, Myelomonocytic, Chronic
-
M.D. Anderson Cancer CenterRecruitingChronic Myelomonocytic Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2United States
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndrome | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Chronic Myelomonocytic Leukemia-0United States
-
Mayo ClinicRecruitingRecurrent Chronic Myelomonocytic Leukemia | Refractory Chronic Myelomonocytic LeukemiaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingMyelomonocytic LeukemiaFrance
-
University of UtahCelgeneCompletedChronic Myelomonocytic LeukemiaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieCelgene CorporationUnknownChronic Myelomonocytic LeukemiaAustria
-
Humanigen, Inc.CompletedChronic Myelomonocytic Leukemia (CMML)United States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationCompletedMyelomonocytic LeukemiaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Myelomonocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Fondazione Italiana Sindromi Mielodisplastiche-ETSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteCompletedChronic Myelomonocytic LeukemiaItaly